Cargando…

Creation and Internal Validation of a Clinical Predictive Model for Fluconazole Resistance in Patients With Candida Bloodstream Infection

BACKGROUND: Fluconazole is recommended as first-line therapy for candidemia when risk of fluconazole resistance (fluc-R) is low. Lack of methods to estimate resistance risk results in extended use of echinocandins and prolonged hospitalization. This study aimed to develop a clinical predictive model...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rauseo, Adriana M, Olsen, Margaret A, Stwalley, Dustin, Mazi, Patrick B, Larson, Lindsey, Powderly, William G, Spec, Andrej
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Major Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472663/ https://www.ncbi.nlm.nih.gov/pubmed/36119958 http://dx.doi.org/10.1093/ofid/ofac447

Ejemplares similares

168. Creation and Internal Validation of a Clinical Predictive Model for Fluconazole Resistance in Patients with Candida Bloodstream Infection
por: Rauseo, Adriana M, et al.
Publicado: (2020)

Creation and Assessment of a Clinical Predictive Calculator and Mortality Associated With Candida krusei Bloodstream Infections
por: Kronen, Ryan, et al.
Publicado: (2018)

376. Predictive Model for Fluconazole Resistance in Patient With Candida Bloodstream Infection
por: Aljorayid, Abdullah, et al.
Publicado: (2018)

Risk Factors and Mortality Associated with Candida krusei Bloodstream Infections
por: Kronen, Ryan, et al.
Publicado: (2017)

Risk Predictive Model for 90-Day Mortality in Candida Bloodstream Infections
por: Lin, Charlotte, et al.
Publicado: (2017)

Risk Factors Predicting Candida glabrata Bloodstream Infection
por: O’Halloran, Jane, et al.
Publicado: (2017)

Long-Term Mortality after Histoplasma Infection in People with HIV
por: Cherabie, Joseph, et al.
Publicado: (2021)

End-Stage Liver Disease Is a Strong Predictor of Early Mortality in Cryptococcosis
por: Spec, Andrej, et al.
Publicado: (2015)

Management of Histoplasmosis by Infectious Disease Physicians
por: Mazi, Patrick B, et al.
Publicado: (2022)

Hope on the Horizon: Novel Fungal Treatments in Development
por: Rauseo, Adriana M, et al.
Publicado: (2020)

Increasing Age Has Limited Impact on Risk of Clostridium difficile Infection in an Elderly Population
por: Olsen, Margaret A, et al.
Publicado: (2018)

Increased Incidence and Risk of Septicemia and Urinary Tract Infection After Clostridioides difficile Infection
por: Olsen, Margaret A, et al.
Publicado: (2023)

AIDS-Defining Illnesses at Initial Diagnosis of HIV in a Large Guatemalan Cohort
por: Reinhardt, Samuel W, et al.
Publicado: (2017)

Validation Study of a Clinical Predictive Model for Fluconazole Resistance in Patients With Candida Bloodstream Infection
por: Collis, Brennan, et al.
Publicado: (2023)

Reply to Collis et al.
por: Rauseo, Adriana M, et al.
Publicado: (2023)

Global Emergence of Resistance to Fluconazole and Voriconazole in Candida parapsilosis in Tertiary Hospitals in Spain During the COVID-19 Pandemic
por: Trevijano-Contador, Nuria, et al.
Publicado: (2022)

Infectious Diseases Consultation Reduces 30-Day and 1-Year All-Cause Mortality for Multidrug-Resistant Organism Infections
por: Burnham, Jason P, et al.
Publicado: (2018)

Clonality of Fluconazole-Nonsusceptible Candida tropicalis in Bloodstream Infections, Taiwan, 2011–2017
por: Chen, Pao-Yu, et al.
Publicado: (2019)

Fluconazole-Resistant Candida glabrata Bloodstream Isolates, South Korea, 2008–2018
por: Won, Eun Jeong, et al.
Publicado: (2021)

Minimum Inhibitory Concentration Distribution of Fluconazole Against Cryptococcus Species and the Fluconazole Exposure Prediction Model
por: Chesdachai, Supavit, et al.
Publicado: (2019)

1699. Presentations and Outcomes of Histoplasma capsulatum Infection Vary by Immune Status: A Retrospective Cohort Study
por: Franklin, Alexander, et al.
Publicado: (2019)

1085. Epidemiology and Outcomes of Histoplasmosis in Transplant Recipients
por: Rutjanawech, Sasinuch, et al.
Publicado: (2020)

395. Missed Opportunities for Diagnosis of Cryptococcal Disease in Patients From Florida
por: Salazar, Ana S, et al.
Publicado: (2018)

Potential missed opportunities for diagnosis of cryptococcosis and the association with mortality: A cohort study
por: Salazar, Ana S., et al.
Publicado: (2020)

2885. Increased incidence of fluconazole-resistant Candida parapsilosis bloodstream infections in Atlanta, Georgia 2021
por: Witt, Lucy S, et al.
Publicado: (2023)

Epidemiology of Cryptococcosis and Cryptococcal Meningitis in a Large Retrospective Cohort of Patients After Solid Organ Transplantation
por: George, Ige A., et al.
Publicado: (2017)

2883. Comparative outcomes following Candida bloodstream infections in patients with left ventricular assist devices (LVAD)
por: Mansoor, Armaghan-e-Rehman, et al.
Publicado: (2023)

Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting?
por: Vena, Antonio, et al.
Publicado: (2022)

Successful fluconazole combined with caspofungin treatment of candida bloodstream infection in preterm infant: A case report
por: Yuan, Gaole, et al.
Publicado: (2021)

Presentation and Outcome of Cryptococcal Infection Varies by Predisposing Illness
por: Raval, Krunal, et al.
Publicado: (2017)

Fluconazole impacts the extracellular matrix of fluconazole-susceptible and -resistant Candida albicans and Candida glabrata biofilms
por: Panariello, Beatriz Helena Dias, et al.
Publicado: (2018)

1030. Risk Predictive Model for Candida Endocarditis in Patients with Candidemia: A 12-year Experience in a Single Tertiary Care Hospital
por: Foong, Kap Sum, et al.
Publicado: (2018)

In Vitro Fluconazole and Voriconazole Susceptibilities of Candida Bloodstream Isolates in Korea: Use of the CLSI and EUCAST Epidemiological Cutoff Values
por: Jang, Min Joong, et al.
Publicado: (2013)

The relationship between the use of fluconazole & the incidence of fluconazole-resistant Candida species
por: Kuo, Chia-Chang, et al.
Publicado: (2014)

Ambroxol Hydrochloride Combined with Fluconazole Reverses the Resistance of Candida albicans to Fluconazole
por: Li, Xiuyun, et al.
Publicado: (2017)

Synergistic Antifungal Activity of Chitosan with Fluconazole against Candida albicans, Candida tropicalis, and Fluconazole-Resistant Strains
por: Lo, Wei-Hsuan, et al.
Publicado: (2020)

Retrospective Study of Cryptococcal Meningitis With Elevated Minimum Inhibitory Concentration to Fluconazole in Immunocompromised Patients
por: Nasri, Hashem, et al.
Publicado: (2016)

Antifungal Susceptibility to Amphotericin B, Fluconazole, Voriconazole, and Flucytosine in Candida Bloodstream Isolates from 15 Tertiary Hospitals in Korea
por: Jung, Sook-In, et al.
Publicado: (2012)

Fluconazole-Resistant Candida parapsilosis Bloodstream Isolates with Y132F Mutation in ERG11 Gene, South Korea
por: Choi, Yong Jun, et al.
Publicado: (2018)

Molecular and Clinical Features of Fluconazole Non-susceptible Candida albicans Bloodstream Isolates Recovered in Korean Multicenter Surveillance Studies
por: Choi, Min Ji, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4cu4if8k455v3bcdffdcltu46j